{
    "clinical_study": {
        "@rank": "161391", 
        "acronym": "CALM-FIM_US", 
        "arm_group": {
            "arm_group_label": "MobiusHD\u2122", 
            "arm_group_type": "Experimental", 
            "description": "MobiusHD\u2122"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the safety and performance of the MobiusHD system in subjects with resistant\n      hypertension."
        }, 
        "brief_title": "Controlling and Lowering Blood Pressure With The MOBIUSHD\u2122", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "This is an open-label, multicenter, first-in-man clinical trial to be conducted inside the\n      United States. Eligible subjects with stage 2 resistant systemic arterial hypertension\n      currently being treated with a minimum of three (3) anti-hypertensive drugs, who consent to\n      study participation will be assigned to treatment with the MobiusHD system.\n\n      Potential study participants will be consented and then screened at two (2) baseline visits\n      beginning at least 30 days prior to MobiusHD placement. Qualified patients will undergo\n      placement of the MobiusHD under angiographic visualization, and will then be followed for 36\n      months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Office cuff SBP \u2265 160 mmHg measured per protocol instructions (Appendix IV) following\n             at least one (1) month of maximally tolerated therapy with at least three (3)\n             anti-hypertensive medications, of which at least one (1) must be a diuretic. Any\n             combination medications will be counted per the active ingredient. (For example,\n             Zestoretic (Lisinopril +HCTZ) equals two (2) anti-hypertensive medications)\n\n        Exclusion Criteria:\n\n          -  Known or clinically suspected baroreflex failure or autonomic neuropathy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01831895", 
            "org_study_id": "CALM-FIM_US, CRD0152, G130013"
        }, 
        "intervention": {
            "arm_group_label": "MobiusHD\u2122", 
            "description": "Implant that is placed in the carotid sinus to control hypertension.", 
            "intervention_name": "MobiusHD\u2122", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Hypertension", 
            "Carotid Sinus"
        ], 
        "lastchanged_date": "February 28, 2014", 
        "location": [
            {
                "contact": {
                    "email": "eshwari_kovoor@Fogartyinstitute.org", 
                    "last_name": "Eshwari Kovoor, M.B.B.S., CCRC", 
                    "phone": "650-962-4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Mountain View", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94040"
                    }, 
                    "name": "El Camino Hospital"
                }, 
                "investigator": {
                    "last_name": "James Joye, D.O.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "margaret.norton@ucdmc.ucdavis.edu", 
                    "last_name": "Margaret Norton, BSN", 
                    "phone": "916-734-5671"
                }, 
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95817"
                    }, 
                    "name": "UC Davis Vascular Center"
                }, 
                "investigator": {
                    "last_name": "John Laird, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Theresa Sanders, MN, RN", 
                    "phone": "404-686-3872"
                }, 
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30308"
                    }, 
                    "name": "Emory University"
                }, 
                "investigator": {
                    "last_name": "Chandan Devireddy, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "keb2114@cumc.columbia.edu", 
                    "last_name": "Kate Dalton, MS, RD", 
                    "phone": "212-342-1820"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Ajay Kirtane, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "harveya2@ccf.org", 
                    "last_name": "Adrienne Harvey"
                }, 
                "contact_backup": {
                    "email": "isabelt@ccf.org", 
                    "last_name": "Tony Isabella"
                }, 
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195"
                    }, 
                    "name": "Cleveland Clinic Foundation"
                }, 
                "investigator": {
                    "last_name": "Mehdi Shishehbor, D.O.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "edas@mcw.edu", 
                    "last_name": "Emon Das, M.D.", 
                    "phone": "414-805-2898"
                }, 
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Medical College of Wisconsin - Froedtert Hospital"
                }, 
                "investigator": {
                    "last_name": "Osama O Zaidat, MD, MS", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "CALM-FIM_US -Controlling and Lowering Blood Pressure With the MobiusHD\u2122 - A Prospective Multicenter Safety Study", 
        "overall_contact": {
            "email": "sshetty@vasculardynamics.com", 
            "last_name": "Sujith J Shetty, MBBS", 
            "phone": "650-963-9370"
        }, 
        "overall_official": {
            "affiliation": "West Virginia University", 
            "last_name": "Mark C Bates, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Incidence of serious adverse events (SAEs) and unanticipated adverse device effects (UADE) reported for the study population from implantation through six (6) months of follow-up.", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "6 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01831895"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Decrease in office cuff blood pressure (BP).", 
            "measure": "PERFORMANCE", 
            "safety_issue": "No", 
            "time_frame": "6 Months"
        }, 
        "source": "Vascular Dynamics, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vascular Dynamics, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}